A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension

Clinical trial NCT07650084 · RECRUITING

Trial details

NCT number: NCT07650084
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Chronic Cough

Start date: 2025-11-21
Primary completion: 2027-08-27
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.